See Full Answer There is no "one answer fits all" to this question, as so much about starting TRT as well as coming off of a medication, has to do with the individual's goals of care
this warrants ongoing monitoring No unexpected serious cardiovascular signals were identified during the limited Phase 2 follow-up period, though the trials were neither designed nor powered to assess cardiovascular outcomes, and longer-term data are not yet available At present, the overall safety profile appears broadly consistent with other GLP-1-based therapies, but definitive conclusions cannot be drawn until Phase 3 data and post-marketing surveillance are available
The approval of this first in a new class of cell therapies for solid tumors defines a regulatory path for TIL, which will unlock more innovation in the industry and ultimately benefit patients with cancer, Jason Bock, CEO of CTMC, a joint venture between biotech Resilience and MD Anderson Cancer Center, told BioSpace in an email
This is the time to fine-tune your eating habits and start embracing healthier patterns, which will serve you well as the dosage increases